|
Volumn 36, Issue 1, 1998, Pages 23-28
|
E 4021, a cGMP phosphodiesterase inhibitor, is a selective pulmonary vasodilator in chronically hypoxic pulmonary hypertensive rats
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
1 [6 CHLORO 4 (3,4 METHYLENEDIOXYBENZYLAMINO) 2 QUINAZOLINYL] 4 PIPERIDINECARBOXYLIC ACID;
CYCLIC GMP PHOSPHODIESTERASE;
PHOSPHODIESTERASE INHIBITOR;
PIPERIDINE DERIVATIVE;
QUINAZOLINE DERIVATIVE;
VASODILATOR AGENT;
ANIMAL;
ANOXIA;
ARTICLE;
BLOOD PRESSURE;
CHRONIC DISEASE;
DRUG EFFECT;
ENZYMOLOGY;
LUNG;
MALE;
METABOLISM;
PATHOPHYSIOLOGY;
PULMONARY ARTERY;
PULMONARY HYPERTENSION;
RAT;
SPRAGUE DAWLEY RAT;
3',5'-CYCLIC-GMP PHOSPHODIESTERASE;
ANIMALS;
ANOXIA;
BLOOD PRESSURE;
CHRONIC DISEASE;
HYPERTENSION, PULMONARY;
LUNG;
MALE;
PHOSPHODIESTERASE INHIBITORS;
PIPERIDINES;
PULMONARY ARTERY;
QUINAZOLINES;
RATS;
RATS, SPRAGUE-DAWLEY;
VASODILATOR AGENTS;
|
EID: 0031609767
PISSN: 13433490
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (0)
|